The $273B skincare market is filled with generic products that fail to address individual biological needs. This company is redefining skincare at the molecular level by integrating AI-powered compound screening, genetic insights, and epigenetic research to develop truly personalized treatments that reverse skin aging, repair DNA damage, and enhance long-term skin health.
Unlike traditional skincare brands that rely on one-size-fits-all formulations, this company’s proprietary technology analyzes skin age and genetic markers to create customized, high-performance solutions tailored to each individual’s biology. With exclusive IP, scientific backing from leading researchers, and a strong first-mover advantage in biotech-driven beauty, it is poised to disrupt the market.
Currently raising funds to accelerate clinical validation and commercialization, this is a rare opportunity to invest early in the future of precision skincare—where science, AI, and genetics converge to deliver results traditional brands simply cannot match.
View the deck through the link below. Some unique identifiers have been removed. For access to detailed materials, please reach to us or your point of contact, as full decks are only shared upon request to maintain confidentiality and exclusivity.
View Pitch Deck